TLR9 and systemic lupus erythematosus: Finally, livers from the highest dose of SLE supplementation expressed less mRNA of Collagen type 1 α1 (Col1a1, −48%, p = 0.01), Tissue inhibitor of metalloproteinase 1 (Timp1, −50%, p < 0.05), Transforming growth factor β1 (Tgf-β1, −31%, p < 0.05), and Toll-like receptor 9 (Tlr9, −50%, p < 0.001) implied in fibrogenesis and/or inflammation.